Discover
IMNN
Imunon, Inc.
1.88
2 x 1.36
2 x 2.32
bid
ask
+
0.10
5.62%
2 @ 04:00 PM
1.87 -0.01 (0.53%)
| Ytd | -50.66% | |
| 1y | -81.51% |
1.75
day range
1.90
1.70
52 week range
10.70
| Open | 1.85 | Prev Close | 1.78 | Low | 1.75 | High | 1.90 | Mkt Cap | 7.90M |
| Vol | 48.34K | Avg Vol | 52.93K | EPS | -4.52 | P/E | N/A | Forward P/E | -0.73 |
| Beta | 2.13 | Short Ratio | 3.31 | Inst. Own | 7.03% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 2.29 | 200-d Avg | 3.46 | 1yr Est | 13.20 |
IMNN News
benzinga.com
Imunon Says Jeffrey Church To Retire As Interim CFO Effective July 1, 2026; Appoints Josh Blacher As
On June 29, 2026, Jeffrey Church informed Imunon, Inc. (the "Company") of his intent to ret
benzinga.com
IMUNON Receives Independent Data Monitoring Committee Recommended Continuation Of Pivotal Phase 3 OV
IMUNON, Inc. (NASDAQ:IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated im
benzinga.com
IMUNON Enters Into Definitive Agreements For $10M In Preferred Stock And Secured Notes
Includes up-front issuance of preferred stock for $2.5 million and secured promissory notes for $7.7